Abstract
The rapidly growing knowledge in molecular biology opened new methodological approaches, pharmacological targets, such as gene transfer or application of antisense oligomers. It is necessary to be familiar with the benefits and drawbacks of gene therapy to avoid the traps of unrealistic expectations and hopes, to solve moral and practical problems of gene manipulations and to find its proper values and rationals in the management of malignant tumors.
Original language | Hungarian |
---|---|
Pages (from-to) | 2609-2613 |
Number of pages | 5 |
Journal | Orvosi Hetilap |
Volume | 133 |
Issue number | 41 |
Publication status | Published - Oct 11 1992 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
Cite this
Génterápia alkalmazásának elvi lehetöségei malignus kórképekben. / Kópper, L.
In: Orvosi Hetilap, Vol. 133, No. 41, 11.10.1992, p. 2609-2613.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Génterápia alkalmazásának elvi lehetöségei malignus kórképekben.
AU - Kópper, L.
PY - 1992/10/11
Y1 - 1992/10/11
N2 - The rapidly growing knowledge in molecular biology opened new methodological approaches, pharmacological targets, such as gene transfer or application of antisense oligomers. It is necessary to be familiar with the benefits and drawbacks of gene therapy to avoid the traps of unrealistic expectations and hopes, to solve moral and practical problems of gene manipulations and to find its proper values and rationals in the management of malignant tumors.
AB - The rapidly growing knowledge in molecular biology opened new methodological approaches, pharmacological targets, such as gene transfer or application of antisense oligomers. It is necessary to be familiar with the benefits and drawbacks of gene therapy to avoid the traps of unrealistic expectations and hopes, to solve moral and practical problems of gene manipulations and to find its proper values and rationals in the management of malignant tumors.
UR - http://www.scopus.com/inward/record.url?scp=0027117880&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027117880&partnerID=8YFLogxK
M3 - Article
C2 - 1408096
AN - SCOPUS:0027117880
VL - 133
SP - 2609
EP - 2613
JO - Orvosi Hetilap
JF - Orvosi Hetilap
SN - 0030-6002
IS - 41
ER -